Sign In
Buy SNY
$44.38
+2.01 (+4.74%)
At Close: Jun 04, 2026
Sanofi (SNY) Q3 Earnings Beat, Dupixent, Flu Jabs Push Sales
02:18pm, Friday, 28'th Oct 2022
Sanofi (SNY) beats third-quarter estimates for earnings and sales. Dupixent and flu vaccines drive sales growth.
Sanofi Jumps As Strong Third-Quarter Profit Leads To Guidance Boost
09:02am, Friday, 28'th Oct 2022
Sanofi stock jumped Friday after the company reported better-than-expected third-quarter profit, leading to a guidance boost. The post Sanofi Jumps As Strong Third-Quarter Profit Leads To Guidance Boo
Sanofi posts higher sales but $2.07 billion net profit misses forecasts
02:09am, Friday, 28'th Oct 2022
By Cecilia Butini
2 High-Yielding Dividend Stocks That Haven't Been This Cheap in Years
10:00am, Friday, 14'th Oct 2022
Is now the time to buy Sanofi and Intel?
Sanofi CEO on using AI to support drug trials
03:52pm, Tuesday, 11'th Oct 2022
Paul Hudson, CEO of Sanofi, joins 'Power Lunch' to discuss solutions-oriented approaches for the pharmaceutical industry, and implementing AI technology in clinical trials to improve the probability o
2 Top Healthcare Stocks to Buy Right Now
09:35am, Saturday, 08'th Oct 2022
Healthcare is about as sticky of a business model as you'll find.
7 Under-$50 Stocks to Buy to Tap Into a Hidden Bull Market
11:24am, Friday, 07'th Oct 2022
Although crimson seems to be the shade of the moment in the equities sector, by targeting under-$50 stocks to buy, astute and daring investors may be able to tap into a hidden bull market. How can thi
Sanofi (SNY) Relies on Dupixent and Vaccines to Drive Growth
10:32am, Tuesday, 04'th Oct 2022
Dupixent has become the key top-line driver for Sanofi (SNY). Sanofi possesses a leading vaccine portfolio, which has become the primary top-line driver.
Here's Why the Post-Pandemic World May Be Even Better for This Vaccine Maker
06:00am, Saturday, 01'st Oct 2022
Moderna's billion-dollar revenue may be just getting started.
BlackRock's DeSpirito: Brace For Stubborn Inflation
07:00am, Friday, 30'th Sep 2022
Inflation is easing, says a top thinker for BlackRock, the world's largest asset manager. But it's not falling to what Americans have grown used to.
Sanofi's (SNY) Dupixent Gets FDA Nod for Prurigo Nodularis
12:47pm, Thursday, 29'th Sep 2022
The FDA approves Sanofi (SNY) and its partner Regeneron's Dupixent (dupilumab) for the treatment of adult patients with prurigo nodularis.
Sanofi (SNY) Moves to Buy: Rationale Behind the Upgrade
01:33pm, Tuesday, 20'th Sep 2022
Sanofi (SNY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
SNY vs. NVO: Which Stock Should Value Investors Buy Now?
12:48pm, Tuesday, 20'th Sep 2022
SNY vs. NVO: Which Stock Is the Better Value Option?
Sanofi (SNY) Gets CHMP Nod for Enjaymo in Hemolytic Anemia
01:32pm, Monday, 19'th Sep 2022
The CHMP recommends authorizing Sanofi's (SNY) Enjaymo as a treatment for hemolytic anemia in patients with cold agglutinin disease (CAD). The CHMP endorses SNY's RSV vaccine for use in infants.
2 Biotech Stocks You Can Buy and Hold for the Next Decade
09:37am, Monday, 19'th Sep 2022
It's hard to imagine a world in which pharmaceutical spending doesn't increase year in and year out.
